XML 13 R4.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Revenues    
License revenues$ 936,000$ 107,000$ 1,110,000$ 281,000
Sponsored research and development0030,0000
Royalties23,00020,00064,00053,000
Product sales82,0000138,0000
Total revenues1,041,000127,0001,342,000334,000
Expenses    
Research and development1,063,0001,199,0003,243,0002,718,000
Product costs454,0000812,0000
General and administrative1,252,0001,165,0003,297,0003,316,000
Depreciation and amortization56,00059,000176,000179,000
Total expenses2,825,0002,423,0007,528,0006,213,000
Loss from operations(1,784,000)(2,296,000)(6,186,000)(5,879,000)
Interest and miscellaneous income1,283,00038,0001,291,000554,000
Interest and other expense(237,000)(152,000)(760,000)(444,000)
Gain on change in fair value of derivative - warrants1,138,000146,0003,312,0006,384,000
Loss on change in fair value of derivative - preferred stock(50,000)(10,455,000)(470,000)(10,455,000)
Total non operating income (expense)2,134,000(10,423,000)3,373,000(3,961,000)
Net loss(350,000)(12,719,000)(2,813,000)(9,840,000)
Less preferred stock dividends447,000452,0001,327,0001,340,000
Net loss allocable to common stockholders$ (97,000)$ (13,171,000)$ (4,140,000)$ (11,180,000)
Net loss allocable to common stockholders$ 0.00$ (0.83)$ (0.21)$ (0.73)
Weighted average basic and diluted common shares outstanding19,503,38315,774,27319,378,57915,337,453